Sector: MedicalOPEXA THERAPEUTICS (NASDAQ: OPXA)
Headlines
- Opexa to Present at the Merriman Curhan Ford 6th Annual Investor Summit 2009 on November 10, 2009
Nov 05, 2009 08:30 AM | OPXA
- Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update
Nov 04, 2009 08:33 AM | NVS, OPXA
- Late Morning Rollover!
Oct 26, 2009 07:31 PM | AIG, BCRX, GS, JPM, NVAX
- Opexa Triggers Milestone Payment Under Recently Announced Stem Cell Agreement
Sep 23, 2009 08:01 AM | NVS, OPXA
- InvestorSoup.com Issues Technical Trading Outlook for Opexa Therapeutics Inc.
Sep 14, 2009 06:51 AM | BIIB, LJPC, NVS, OPXA
- Opexa to Present at the Rodman & Renshaw 11th Annual Healthcare Conference September 11, 2009
Sep 08, 2009 07:30 AM | NVS, OPXA
- Opexa Reports Additional Favorable Data with Tovaxin(R) for Multiple Sclerosis
Sep 08, 2009 07:00 AM | OPXA
- Global Stem Cell and Regenerative Medicine Index
Feb 17, 2009 09:00 PM | ANPI, ASTM, AXP, BMTI
- PicksThatMove.Com Announces Investment Opinion: Risk and Reward on Momentum Investing
Sep 23, 2009 11:12 AM | CEGE, KERX, OPXA, QTWW, WAVE
- Opexa Therapeutics Reports Second Quarter 2009 Financial Results and Corporate Update
Aug 13, 2009 08:00 AM | OPXA
- Opexa Regains NASDAQ Compliance Following Stem Cell Agreement
Aug 10, 2009 07:51 AM | OPXA
- Opexa Announces Stem Cell Agreement With Leading Global Pharmaceutical Company
Aug 07, 2009 07:53 AM | OPXA
- Opexa Therapeutics Receives Favorable NASDAQ Determination
Jun 09, 2009 08:20 AM | OPXA
- Opexa Therapeutics Reports First Quarter 2009 Financial Results and Closes Private Financing
May 15, 2009 09:24 AM | OPXA
- Opexa to Present Tovaxin® Data at the American Academy of Neurology 2009 Annual Meeting
Apr 27, 2009 07:03 AM | OPXA
- Opexa Publication of Tovaxin® Clinical Data in Journal of Clinical Immunology
Apr 24, 2009 08:02 AM | OPXA
- Opexa Therapeutics Reports Year End 2008 Financial Results
Apr 16, 2009 07:51 AM | OPXA
- Opexa Therapeutics Closes First Tranche of Additional Financing
Apr 16, 2009 07:31 AM | OPXA
- Form 4 Opexa Therapeutics, Inc. For: Nov 16 Filed by: JORDEN DAVID EMERSON (10K)
Nov 16, 2009 03:12 PM
- Form 4 Opexa Therapeutics, Inc. For: Nov 09 Filed by: JORDEN DAVID EMERSON (10K)
Nov 12, 2009 12:09 PM
- Form 4 JORDEN DAVID EMERSON For: Oct 13 (10K)
Oct 14, 2009 02:01 PM
- Form 4 JORDEN DAVID EMERSON For: Sep 11 (10K)
Sep 14, 2009 01:53 PM
- Form 4 Hung David For: Sep 10 (10K)
Sep 10, 2009 07:25 PM
- Form 4 McWilliams David For: Aug 26 (10K)
Aug 27, 2009 04:31 PM
- Form 4 Seaman Scott B For: Aug 26 (10K)
Aug 27, 2009 04:22 PM
- Form 4 Richman Michael For: Aug 26 (10K)
Aug 27, 2009 04:07 PM
- Form 4 JORDEN DAVID EMERSON For: Aug 26 (10K)
Aug 27, 2009 02:20 PM
- Form 4 Hung David For: Aug 20 (10K)
Aug 21, 2009 07:34 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
OPXA
|
Compare to S&P
|
| YTD |
978.95 %
|
792.96 %
|
| 4 Weeks |
-11.56 %
|
-12.52 %
|
| 12 Weeks |
42.36 %
|
34.22 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 100.33 %
|
|
EPS Growth in Last Year: 107.14 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
